1. Home
  2. RSI vs PBLS Comparison

RSI vs PBLS Comparison

Compare RSI & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Street Interactive Inc.

RSI

Rush Street Interactive Inc.

HOLD

Current Price

$31.32

Market Cap

3.6B

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$30.76

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RSI
PBLS
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
RSI
PBLS
Price
$31.32
$30.76
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$28.20
N/A
AVG Volume (30 Days)
2.4M
502.7K
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
933.33
N/A
EPS
0.08
N/A
Revenue
$1,134,428,000.00
N/A
Revenue This Year
$25.44
N/A
Revenue Next Year
$14.27
N/A
P/E Ratio
$391.50
N/A
Revenue Growth
22.76
N/A
52 Week Low
$15.18
$25.56
52 Week High
$34.53
$33.65

Technical Indicators

Market Signals
Indicator
RSI
PBLS
Relative Strength Index (RSI) 49.12 56.52
Support Level $25.56 $26.83
Resistance Level N/A $33.65
Average True Range (ATR) 1.24 2.62
MACD -0.38 0.14
Stochastic Oscillator 17.08 63.76

Price Performance

Historical Comparison
RSI
PBLS

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: